Clinical sample validation in multiple CRC cohorts further confirmed the overexpression of SLCO4A1-AS1 in CRC and increased SLCO4A1-AS1 levels were associated with poor survival. The gene discussed is SLCO4A1; the disease is colorectal carcinoma.